Mouse anti Mouse MHC Class I H-2Kd antibody, clone K3 recognizes the murine MHC Class I H-2Kd haplotype. The major histocompatibility complex (MHC) is a cluster of genes that are important in the immune response to infections. In mice, this complex is referred to as the histocompatibility 2 (H-2) region. There are 3 major MHC class I proteins encoded by the H-2 which are H-2K, H-2L and H-2D. The H- 2K gene is part of the murine H-2 complex on chromosome 17 and there are a large number of variant alleles of this gene.
Mouse anti Mouse MHC Class I H-2Kd antibody, clone K3 recognizes the H-2Kd determinant present on all nucleated cells of mice expressing this MHC class I haplotype.
- Target Species
- Product Form
- Tissue Culture Supernatant - liquid
- Preservative Stabilisers
- Spleen cells from DAB/2 mice.
- Store at +4oC.
DO NOT FREEZE.
This product should be stored undiluted. Should this product contain a precipitate we recommend microcentrifugation before use.
- 18 months from date of despatch.
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of MHC Class I H-2Kd antibody
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
References for MHC Class I H-2Kd antibody
Busund, L.T. et al. (2003) Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo.
Int. J. Cancer. 106: 153-9.